207 related articles for article (PubMed ID: 1762684)
1. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
Pierce RC; Rowlett JK; Bardo MT; Rebec GV
Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
[TBL] [Abstract][Full Text] [Related]
2. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
Fields JZ; Gordon JH
Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
[TBL] [Abstract][Full Text] [Related]
3. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol.
Wolffgramm J; Rommelspacher H; Buck E
Pharmacol Biochem Behav; 1990 Aug; 36(4):907-14. PubMed ID: 2217521
[TBL] [Abstract][Full Text] [Related]
4. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
6. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
7. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
8. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
10. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
Ben-Shachar D; Youdim MB
J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
[TBL] [Abstract][Full Text] [Related]
13. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
[TBL] [Abstract][Full Text] [Related]
14. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
Lai H; Kazi MS; Carino MA; Horita A
Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
[TBL] [Abstract][Full Text] [Related]
15. Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment.
Young KA; Zavodny R; Hicks PB
J Neural Transm Gen Sect; 1991; 86(3):223-8. PubMed ID: 1837997
[TBL] [Abstract][Full Text] [Related]
16. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
[TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves.
Drucker GE; Ritzmann RF; Wichlinski LJ; Engh K; Gordon JH; Fields JZ
Pharmacol Biochem Behav; 1994 Jan; 47(1):141-5. PubMed ID: 8115415
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
Meller E; Bohmaker K; Friedhoff AJ
Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
[TBL] [Abstract][Full Text] [Related]
20. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
Chipkin RE; McQuade RD; Iorio LC
Pharmacol Biochem Behav; 1987 Dec; 28(4):477-82. PubMed ID: 2893388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]